Why Are Tricor and Trilipix So Expensive?

Dr. Sharon Orrange
Dr. Orrange is an Associate Professor of Clinical Medicine in the Division of Geriatric, Hospitalist and General Internal Medicine at the Keck School of Medicine of USC.
Posted on

They shouldn’t be, and it’s sneaky. Read on.

As you know, when a branded medication loses patent protection it will face generic competition, and generics are much cheaper. A drug company can change its brand name drug to a slightly different dosage which allows it to extend its patent. It’s legal, but you will see how crazy it is.

For those of you on Tricor, Trilipix or the generic fenofibrate you should know what has gone on. Abbott Laboratories used this strategy to avoid generic competition for its branded formulations of fenofibrate. This is a medication to lower triglycerides and it is questionable anyway whether it lowers your risk of stroke and heart disease, but they have made quite a bit of money on this drug.

Abbott reformulated fenofibrate several times in the face of generic competition as it lost patent protection:

How can your doctor help?

Dr O.

Drugs featured in this story

Filed under